BL

Investor profile

Barbara Lubash

Angel

Barbara Lubash is an angel investor based in Orange County, California, United States with 8 known investments: CRISPR Therapeutics, Inari Medical, Vividion Therapeutics, Black Diamond Therapeutics, Passage Bio, Audentes Therapeutics, BlueRock Therapeutics and RedBrick Health.

Is Barbara Lubash a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

bar***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Barbara Lubash portfolio companies (8)

  • CRISPR Therapeutics
  • Inari Medical
  • Vividion Therapeutics
  • Black Diamond Therapeutics
  • Passage Bio
  • Audentes Therapeutics
  • BlueRock Therapeutics
  • RedBrick Health

Investor Profile

The listing covers sector Healthcare, and focus areas Biotech, Clinical Trials, Diagnostics and Genomics. Startups operating in these areas may find Barbara Lubash relevant.

Reviewing the investment history helps decide whether there is a realistic fit before reaching out.

Similar investors

Showing 19 of 99

Frequently asked questions

Who is Barbara Lubash?

Barbara Lubash is an angel investor based in Orange County, California, United States with 8 known investments on file, among them CRISPR Therapeutics, Inari Medical and Vividion Therapeutics. The sections above list the sectors attached to that record.

What does Barbara Lubash invest in?

Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Diagnostics and Genomics. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.

How do I contact Barbara Lubash?

An email address, a phone number and a LinkedIn page are on file for Barbara Lubash. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal